NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/05/2025
Back to search
Official data from USPTO
THE PHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
08/05/2025
Trademark type
Combined
Nice classes
41
Filing date
09/15/2024
Registration date
08/05/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/05/2025
Last transaction
08/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/14/2024
First use in commerce
09/14/2024
Drawing code
3
Owner type
16
Owner location
Yardley, PA, US
Examiner
LEE, RAYMOND KANGMIN
Law office
N90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "THE" appearing above the word "PHARM." The "R" in "PHARM" appears as a prescription symbol.
Holders and representatives
Holders
Posimistiq LLC
Representatives
Posimistiq LLC
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Entertainment services in the nature of a television series in the field of comedy
Publications
History of USPTO decisions and trademark events.
14 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/17/2025
PUBO
PUBLISHED FOR OPPOSITION
06/17/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/14/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
05/14/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/14/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
05/14/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/14/2025
DOCK
ASSIGNED TO EXAMINER
03/24/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/23/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/23/2025
NWAP
NEW APPLICATION ENTERED
09/15/2024
Continuous trademark protection
Get notified about every new filing that threatens THE PHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.